Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies

被引:397
|
作者
Fairfoul, Graham [1 ]
McGuire, Lynne I. [1 ]
Pal, Suvankar [1 ,2 ]
Ironside, James W. [1 ]
Neumann, Juliane [3 ]
Christie, Sharon [4 ]
Joachim, Catherine [4 ]
Esiri, Margaret [4 ]
Evetts, Samuel G. [3 ]
Rolinski, Michal [3 ]
Baig, Fahd [3 ]
Ruffmann, Claudio [3 ]
Wade-Martins, Richard [5 ]
Hu, Michele T. M. [3 ]
Parkkinen, Laura [3 ]
Green, Alison J. E. [1 ]
机构
[1] Univ Edinburgh, Western Gen Hosp, Natl CJD Res & Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Western Gen Hosp, Ctr Clin Brain Sci, Edinburgh EH4 2XU, Midlothian, Scotland
[3] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford Parkinsons Dis Ctr, Level 6 West Wing, Oxford OX3 9DU, England
[4] Univ Oxford, John Radcliffe Hosp, Oxford Project Investigate Memory & Ageing OPTIMA, Nuffield Dept Clin Neurosci, Level 6 West Wing, Oxford OX3 9DU, England
[5] Univ Oxford, Oxford Parkinsons Dis Ctr, Dept Physiol Anat & Genet, Le Gros Clark Bldg,South Parks Rd, Oxford OX1 3QX, England
来源
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY | 2016年 / 3卷 / 10期
基金
英国医学研究理事会;
关键词
SLEEP BEHAVIOR DISORDER; PARKINSONS-DISEASE; CEREBROSPINAL-FLUID; BIOMARKERS; COHORT;
D O I
10.1002/acn3.338
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We have developed a novel real-time quaking-induced conversion RT-QuIC-based assay to detect alpha-synuclein aggregation in brain and cerebrospinal fluid from dementia with Lewy bodies and Parkinson's disease patients. This assay can detect alpha-synuclein aggregation in Dementia with Lewy bodies and Parkinson's disease cerebrospinal fluid with sensitivities of 92% and 95%, respectively, and with an overall specificity of 100% when compared to Alzheimer and control cerebrospinal fluid. Patients with neuropathologically confirmed tauopathies (progressive supranuclear palsy; corticobasal degeneration) gave negative results. These results suggest that RT-QuiC analysis of cerebrospinal fluid is potentially useful for the early clinical assessment of patients with alpha-synucleinopathies.
引用
收藏
页码:812 / 818
页数:7
相关论文
共 50 条
  • [21] Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-Synuclein
    Barkovits, Katalin
    Kruse, Niels
    Linden, Andreas
    Toenges, Lars
    Pfeiffer, Kathy
    Mollenhauer, Brit
    Marcus, Katrin
    CELLS, 2020, 9 (02)
  • [22] Sex differences in alpha-synucleinopathies: a systematic review
    Raheel, Kausar
    Deegan, Gemma
    Di Giulio, Irene
    Cash, Diana
    Ilic, Katarina
    Gnoni, Valentina
    Chaudhuri, K. Ray
    Drakatos, Panagis
    Moran, Rosalyn
    Rosenzweig, Ivana
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [23] Enteric Pathologic Manifestations of Alpha-Synucleinopathies
    Punsoni, Michael
    Friedman, Joseph H.
    Resnick, Murray
    Donahue, John E.
    Yang, Dong Fang
    Stopa, Edward G.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (07) : 543 - 548
  • [24] Can infections trigger alpha-synucleinopathies?
    Tulisiak, Christopher T.
    Mercado, Gabriela
    Peelaerts, Wouter
    Brundin, Lena
    Brundin, Patrik
    MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES: VISIONS FOR THE FUTURE, PT A, 2019, 168 : 299 - 322
  • [25] Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study
    Iranzo, Alex
    Fairfoul, Graham
    Ayudhaya, Anutra Chumbala Na
    Serradell, Monica
    Gelpi, Ellen
    Vilaseca, Isabel
    Sanchez-Valle, Raquel
    Gaig, Carles
    Santamaria, Joan
    Tolosa, Eduard
    Riha, Renata L.
    Green, Alison J. E.
    LANCET NEUROLOGY, 2021, 20 (03) : 203 - 212
  • [26] RT-QuIC-based detection of alpha-synuclein seeding activity in brains of dementia with Lewy Body patients and of a transgenic mouse model of synucleinopathy
    Han, Jung-Youn
    Jang, Hyung-Sup
    Green, Alison J. E.
    Choi, Young Pyo
    PRION, 2020, 14 (01) : 88 - 94
  • [27] RT-QuIC and Related Assays for Detecting and Quantifying Prion-like Pathological Seeds of α-Synuclein
    Srivastava, Ankit
    Alam, Parvez
    Caughey, Byron
    BIOMOLECULES, 2022, 12 (04)
  • [28] Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease
    Majbour, Nour K.
    Vaikath, Nishant N.
    van Dijk, Karin D.
    Ardah, Mustafa T.
    Varghese, Shiji
    Vesterager, Louise B.
    Montezinho, Liliana P.
    Poole, Stephen
    Safieh-Garabedian, Bared
    Tokuda, Takahiko
    Teunissen, Charlotte E.
    Berendse, Henk W.
    van de Berg, Wilma D. J.
    El-Agnaf, Omar M. A.
    MOLECULAR NEURODEGENERATION, 2016, 11
  • [29] Alpha-synuclein is a potential biomarker in the serum and CSF of patients with intractable epilepsy
    Hu, Rong
    Luo, Jin
    Wang, Wei
    Wang, Xuefeng
    Xi, Zhiqin
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2015, 27 : 6 - 9
  • [30] Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological Perspective
    Knecht, Luisa
    Folke, Jonas
    Dodel, Richard
    Ross, J. Alexander
    Albus, Alexandra
    NEUROTHERAPEUTICS, 2022, 19 (05) : 1489 - 1502